Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy

Trials

Volumn 14, Issue 1, 2013, Pages

  Lopes, Renato D ^a   Lokhnygina, Yuliya ^a   Hasselblad, Victor ^a   Newby, Kristin L ^a   Yow, Eric ^a   Granger, Christopher B ^a   Armstrong, Paul W ^b   Hochman, Judith S ^c   Mills, James S ^a   Ruzyllo, Witold ^d   Mahaffey, Kenneth W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Clinical outcomes; Creatine kinase MB; Infarct size; ST segment elevation myocardial infarction

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; PEXELIZUMAB;

ARTICLE; CEREBROVASCULAR ACCIDENT; ENZYME ANALYSIS; HEART FAILURE; HEART INFARCTION SIZE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; REPERFUSION; RISK ASSESSMENT; SHOCK; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOLYTIC REPERFUSION THERAPY;

AREA UNDER CURVE; BIOLOGICAL MARKERS; CLINICAL ENZYME TESTS; CREATINE KINASE, MB FORM; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SHOCK; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84878183122     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-123     Document Type: Article

References (35)

1. Shell WE, Sobel BE. Biochemical markers of ischemic injury. Circulation 1976, 53:98-106.
2. Sobel BE, Bresnahan GF, Shell WE, Yoder RD. Estimation of infarct size in man and its relation to prognosis. Circulation 1972, 46:640-648. 10.1161/01.CIR.46.4.640, 5072765.
3. Norris RM, Whitlock RM, Barratt-Boyes C, Small CW. Clinical measurement of myocardial infarct size: modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction. Circulation 1975, 51:614-620. 10.1161/01.CIR.51.4.614, 1116251.
4. Antman EM, Braunwald E. ST-elevation myocardial infarction: pathology, pathophysiology, and clinical features. Heart Disease 2005, 1141-1165. New York: Elsevier Saunders, Braunwald E, 7.
5. Hedström E, Aström-Olsson K, Ohlin H, Frogner F, Carlsson M, Billgren T, Jovinge S, Cain P, Wagner GS, Arheden H. Peak CK-MB and cTnT accurately estimates myocardial infarct size after reperfusion. Scand Cardiovasc J 2007, 41:44-50. 10.1080/14017430601071849, 17365977.
6. Puleo PR, Perryman MB. Noninvasive detection of reperfusion in acute myocardial infarction based on plasma activity of creatine kinase MB subforms. J Am CollCardiol 1991, 17:1047-1052.
7. Hashimoto T, Kambara H, Fudo T, Tamaki S, Nohara R, Takatsu Y, Hattori R, Tokunaga S, Kawai C. Early estimation of acute myocardial infarct size soon after coronary reperfusion using emission computed tomography with technetium-99m pyrophosphate. Am J Cardiol 1987, 60:952-957. 10.1016/0002-9149(87)90331-6, 2823591.
8. Jansen DE, Corbett JR, Buja LM, Hansen C, Ugolini V, Parkey RW, Willerson JT. Quantification of myocardial injury produced by temporary coronary artery occlusion and reflow with technetium-99m-pyrophosphate. Circulation 1987, 75:611-617. 10.1161/01.CIR.75.3.611, 3493088.
9. Grande P, Christiansen C, Pedersen A. Influence of acute myocardial infarct size on acute and one-year mortality. Eur Heart J 1983, 4:20-25.
10. Grande P, Kiilerich S. Relationship between serum CK-MB-estimated acute myocardial infarct size and clinical complications. Acta Med Scand 1984, 215:355-362.
11. Damman P, Beijk MA, Kuijt WJ, Verouden NJ, van Geloven N, Henriques JP, Baan J, Vis MM, Meuwissen M, van Straalen JP, Fischer J, Koch KT, Piek JJ, Tijssen JG, de Winter RJ. Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. J Am Coll Cardiol 2011, 57:29-36. 10.1016/j.jacc.2010.06.053, 21185497.
12. Mahaffey KW, Roe MT, Kilaru R, Alexander JH, Van de Werf F, Califf RM, Simoons ML, Topol EJ, Harrington RA. Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials. Eur Heart J 2007, 28:425-432. 10.1093/eurheartj/ehl483, 17267458.
13. Galla JM, Mahaffey KW, Sapp SK, Alexander JH, Roe MT, Ohman EM, Granger CB, Armstrong PW, Harrington RA, White HD, Simoons ML, Newby LK, Califf RM, Topol EJ. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials. Am Heart J 2006, 151:16-24. 10.1016/j.ahj.2005.01.045, 16368286.
14. Roe MT, Mahaffey KW, Kilaru R, Alexander JH, Akkerhuis KM, Simoons ML, Harrington RA, Tardiff BE, Granger CB, Ohman EM, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Topol EJ. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. Eur Heart J 2004, 25:313-321. 10.1016/j.ehj.2003.12.009, 14984920.
15. Alexander JH, Sparapani RA, Mahaffey KW, Deckers JW, Newby LK, Ohman EM, Corbalán R, Chierchia SL, Boland JB, Simoons ML, Califf RM, Topol EJ, Harrington RA. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. JAMA 2000, 283:347-353. 10.1001/jama.283.3.347, 10647797.
16. Fioretti P, Sclavo M, Brower RW, Simoons ML, Hugenholtz PG. Prognosis of patients with different peak serum creatine kinase levels after first myocardial infarction. Eur Heart J 1985, 6:473-478.
17. Cox JR, Roberts R, Ambos HD, Oliver GC, Sobel BE. Relations between enzymatically estimated myocardial infarct size and early ventricular dysrhythmia. Circulation 1976, 53(Suppl 3):I150-I155.
18. Roberts R, Husain A, Ambos HD, Oliver GC, Cox JR, Sobel BE. Relations between infarct size and ventricular arrhythmia. Br Heart J 1975, 37:1169-1175. 10.1136/hrt.37.11.1169, 482935, 53056.
19. Bleifeld W, Mathey D, Hanrath P, Buss H, Effert S. Infarct size estimated from serial serum creatine phosphokinase in relation to left ventricular hemodynamics. Circulation 1977, 55:303-311. 10.1161/01.CIR.55.2.303, 832346.
20. Rogers WJ, McDaniel HG, Smith LR, Mantle JA, Russell RO, Rackley CE. Correlation of angiographic estimates of infarct size and accumulated release of creatine kinase MB isoenzyme in man. Circulation 1977, 56:199-204. 10.1161/01.CIR.56.2.199, 872311.
21. Saltissi S, Robinson PS, Webb-Peploe MM, Coltart DJ, Croft DN. Advantages of technetium pyrophosphate scintigraphy over plasma enzyme analysis in estimation of anterior myocardial infarct size. Br Heart J 1981, 45:173. 10.1136/hrt.45.2.173, 482506, 6257264.
22. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JA. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998, 97:765-772. 10.1161/01.CIR.97.8.765, 9498540.
23. Granger CB, Mahaffey KW, Weaver WD, Theroux P, Hochman JS, Filloon TG, Rollins S, Todaro TG, Nicolau JC, Ruzyllo W, Armstrong PW, COMMA Investigators Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation 2003, 108:1184-1190. 10.1161/01.CIR.0000087447.12918.85, 12925454, COMMA Investigators.
24. Mahaffey KW, Granger CB, Nicolau JC, Ruzyllo W, Weaver WD, Theroux P, Hochman JS, Filloon TG, Mojcik CF, Todaro TG, Armstrong PW, COMPLY Investigators Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial. Circulation 2003, 108:1176-1183. 10.1161/01.CIR.0000087404.53661.F8, 12925455, COMPLY Investigators.
25. Shell WE, Lavelle JF, Covell JW, Sobel BE. Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction. J Clin Invest 1973, 52:2579-2590. 10.1172/JCI107450, 302518, 4729051.
26. Vollmer RT, Christenson RH, Reimer K, Ohman EM. Temporal creatine kinase curves in acute myocardial infarction. Am J ClinPathol 1993, 100:293-298.
27. Schwerdt H, Ozbek C, Frohlig G, Schieffer H, Bette L. Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction. Cardiovasc Res 1990, 24:328-334. 10.1093/cvr/24.4.328, 2189569.
28. Hartley HO. The modified Gauss-Newton method for the fitting of non-linear regression functions by least squares. Technometrics 1961, 3:269-280.
29. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s?. Circulation 1993, 88:750-763. 10.1161/01.CIR.88.2.750, 8339435.
30. Wagner GS. Optimal use of serum enzyme levels in the diagnosis of acute myocardial infarction. Arch Intern Med 1982, 140:33-38.
31. Smith AF, Radford D, Wong CP, Oliver MF. Creatine kinase-MB isoenzyme studies in diagnosis of myocardial infarction. Br Heart J 1976, 38:225-232. 10.1136/hrt.38.3.225, 485826, 1259837.
32. Puleo PR, Meyer D, Wathen C, Tawa CB, Wheeler S, Hamburg RJ, Ali N, Obermueller SD, Triana JF, Zimmerman JL. Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N EnglJ Med 1994, 331:561-566.
33. Grande P, Granborg J, Clemmensen P, Sevilla DC, Wagner NB, Wagner GS. Indices of reperfusion in patients with acute myocardial infarction using characteristics of the CK-MB time-activity curve. Am Heart J 1991, 122:400-408. 10.1016/0002-8703(91)90992-Q, 1907088.
34. Smith JL, Ambos HD, Gold HK, Muller JE, Poole WK, Raabe DS, Rude RE, Passamani E, Braunwald E, Sobel BE, Roberts R. Enzymatic estimation of myocardial infarct size when early creatine kinase values are not available. Am J Cardiol 1983, 51:1294-1300. 10.1016/0002-9149(83)90301-6, 6846157.
35. Hackel DB, Reimer KA, Ideker RE, Mikat EM, Hartwell TD, Parker CB, Braunwald EB, Buja M, Gold HK, Jaffe AS, Muller JE, Raabe DS, Rude RE, Sobel BE, Stone PH, Roberts R, and the MILIS Study Group Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation 1984, 70:824-835. 10.1161/01.CIR.70.5.824, 6488496, and the MILIS Study Group.